Screening for TP53 rearrangements in families with the Li–Fraumeni syndrome reveals a complete deletion of the TP53 gene

被引:0
|
作者
Gaëlle Bougeard
Laurence Brugières
Agnès Chompret
Paul Gesta
Françoise Charbonnier
Alexander Valent
Cosette Martin
Grégory Raux
Jean Feunteun
Brigitte Bressac-de Paillerets
Thierry Frébourg
机构
[1] Inserm EMI 9906 – IFRMP,Department of Pediatrics
[2] Faculty of Medicine,Department of Genetics
[3] Institut Gustave Roussy,Department of Cellular Genomics of Cancers
[4] Oncology,Department of Clinical Biology
[5] Centre Hospitalier,undefined
[6] CHU of Rouen,undefined
[7] Institut Gustave Roussy,undefined
[8] UMR 8125,undefined
[9] Institut Gustave Roussy,undefined
[10] Institut Gustave Roussy,undefined
来源
Oncogene | 2003年 / 22卷
关键词
Li–Fraumeni syndrome; deletion; PCR;
D O I
暂无
中图分类号
学科分类号
摘要
The absence of detectable germline TP53 mutations in a fraction of families with Li–Fraumeni syndrome (LFS) has suggested the involvement of other genes, but this hypothesis remains controversial. The density of Alu repeats within the TP53 gene led us to search genomic rearrangements of TP53 in families without detectable TP53 mutation. To this aim, we adapted the quantitative multiplex PCR of short fluorescent fragments (QMPSF) method to the analysis of the 11 exons of TP53. We analysed 98 families, either fulfilling (six families) or partially meeting (92 families) the criteria for LFS, and in which classical methods had failed to reveal TP53 alterations. We identified, in a large family fulfilling the criteria for LFS, a complete heterozygous deletion of TP53. Additional QMPSF analyses indicated that this deletion, which partially removed the centromeric FLJ10385 locus, covered approximately 45 kb. This deletion was shown to result from a complex rearrangement involving two distinct Alu-mediated recombinations. We conclude that TP53 germline rearrangements occur as rare events, but must be considered in LFS families without detectable point TP53 mutation.
引用
收藏
页码:840 / 846
页数:6
相关论文
共 50 条
  • [31] Two TP53 germline mutations in a classical Li-Fraumeni syndrome family
    Liselotte P. van Hest
    Mariëlle W. G. Ruijs
    Anja Wagner
    Conny A. van der Meer
    Senno Verhoef
    Laura J. van‘t Veer
    Hanne Meijers-Heijboer
    Familial Cancer, 2007, 6 : 311 - 316
  • [32] Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
    Saba, Karim H.
    Difilippo, Valeria
    Kovac, Michal
    Cornmark, Louise
    Magnusson, Linda
    Nilsson, Jenny
    van den Bos, Hilda
    Spierings, Diana C. J.
    Bidgoli, Mahtab
    Jonson, Tord
    Sumathi, Vaiyapuri P.
    Brosjoe, Otte
    Staaf, Johan
    Foijer, Floris
    Styring, Emelie
    Nathrath, Michaela
    Baumhoer, Daniel
    Nord, Karolin H.
    JOURNAL OF PATHOLOGY, 2024, 262 (02): : 147 - 160
  • [33] A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
    Masaya Kai
    Makoto Kubo
    Sawako Shikada
    Saori Hayashi
    Takafumi Morisaki
    Mai Yamada
    Yuka Takao
    Akiko Shimazaki
    Yurina Harada
    Kazuhisa Kaneshiro
    Yusuke Mizuuchi
    Koji Shindo
    Masafumi Nakamura
    Surgical Case Reports, 8
  • [34] The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
    Leroy, Bernard
    Fournier, Jean Louis
    Ishioka, Chikashi
    Monti, Paola
    Inga, Alberto
    Fronza, Gilberto
    Soussi, Thierry
    NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D962 - D969
  • [35] Chromosome instability in fibroblasts derived from Li-Fraumeni syndrome families without TP53 mutations
    Boyle, JM
    Spreadborough, A
    Greaves, MJ
    Birch, JM
    Scott, D
    BRITISH JOURNAL OF CANCER, 2000, 83 (09) : 1136 - 1138
  • [36] LFSpro: A risk assessment tool to estimate TP53 mutation status in families with Li-Fraumeni syndrome
    Peng, Gang
    Bojadzieva, Jasmina
    Ballinger, Mandy L.
    Thomas, David M.
    Strong, Louise
    Wang, Wenyi
    CANCER RESEARCH, 2015, 75
  • [37] Li-Fraumeni syndrome: a germline TP53 splice variant reveals a novel physiological alternative transcript
    Louis, Jeanne
    Rolain, Marion
    Levacher, Corentin
    Baudry, Karen
    Pujol, Pascal
    Ruminy, Philippe
    Desurmont, Stephanie Baert
    Bou, Jacqueline
    Bouvignies, Emilie
    Coutant, Sophie
    Kasper, Edwige
    Lienard, Gwendoline
    Vasseur, Stephanie
    Vezain, Myriam
    Houdayer, Claude
    Charbonnier, Francoise
    Bougeard, Gaelle
    JOURNAL OF MEDICAL GENETICS, 2025,
  • [38] Li-Fraumeni syndrome, P53 gene, rhabdomyosarcomaRhabdomyosarcoma in a patient with germline TP53 gene mutations: A case report
    Chen, Li-Ping
    Zhang, Wei-Ling
    Huang, Dong-Sheng
    KUWAIT MEDICAL JOURNAL, 2020, 52 (04): : 450 - 454
  • [39] TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome
    Ribi, Sebastian
    Baumhoer, Daniel
    Lee, Kristy
    Edison
    Teo, Audrey S. M.
    Madan, Babita
    Zhang, Kang
    Kohlmann, Wendy K.
    Yao, Fei
    Lee, Wah Heng
    Hoi, Qiangze
    Cai, Shaojiang
    Woo, Xing Yi
    Tan, Patrick
    Jundt, Gernot
    Smida, Jan
    Nathrath, Michaela
    Sung, Wing-Kin
    Schiffman, Joshua D.
    Virshup, David M.
    Hillmer, Axel M.
    ONCOTARGET, 2015, 6 (10) : 7727 - 7740
  • [40] TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
    Hu, Wanglai
    Chen, Song
    Thorne, Rick F.
    Wu, Mian
    AUTOPHAGY: BIOLOGY AND DISEASES: BASIC SCIENCE, 2019, 1206 : 127 - 149